Norges Bank
EPZM

Norges Bank’s Epizyme, Inc EPZM Stock Holding History

Norges Bank’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-238,162
Closed -$274K – 2210
2022
Q1 		$274K Sell
238,162
-580,691
-71% -$947K ﹤0.01% 2128
2021
Q4 		$2.05M Buy
818,853
+72,475
+10% +$285K ﹤0.01% 2035
2021
Q3 		$3.82M Hold
746,378
– – ﹤0.01% 1965
2021
Q2 		$6.2M Sell
746,378
-159,187
-18% -$1.34M ﹤0.01% 1866
2021
Q1 		$7.89M Sell
905,565
-138,142
-13% -$1.43M ﹤0.01% 1842
2020
Q4 		$11.3M Sell
1,043,707
-156,859
-13% -$1.94M ﹤0.01% 1740
2020
Q3 		$14.3M Sell
1,200,566
-93,420
-7% -$1.25M ﹤0.01% 1601
2020
Q2 		$20.8M Sell
1,293,986
-48,918
-4% -$854K 0.01% 1402
2020
Q1 		$20.8M Buy
1,342,904
+457,287
+52% +$9.82M 0.01% 1217
2019
Q4 		$21.8M Hold
885,617
– – 0.01% 1476
2019
Q3 		$9.13M Hold
885,617
– – ﹤0.01% 1805
2019
Q2 		$11.1M Sell
885,617
-245,077
-22% -$3.15M ﹤0.01% 1767
2019
Q1 		$14M Hold
1,130,694
– – ﹤0.01% 1686
2018
Q4 		$6.96M Hold
1,130,694
– – ﹤0.01% 1854
2018
Q3 		$12M Buy
1,130,694
+322,918
+40% +$3.69M ﹤0.01% 1763
2018
Q2 		$10.9M Buy
807,776
+126,182
+19% +$1.96M ﹤0.01% 1783
2018
Q1 		$12.1M Sell
681,594
-399,408
-37% -$6.75M ﹤0.01% 1680
2017
Q4 		$13.6M Sell
1,081,002
-99,502
-8% -$1.45M ﹤0.01% 1627
2017
Q3 		$22.5M Hold
1,180,504
– – 0.01% 1367
2017
Q2 		$17.8M Buy
1,180,504
+561,913
+91% +$8.49M 0.01% 1488
2017
Q1 		$10.6M Buy
618,591
+125,960
+26% +$1.68M ﹤0.01% 1715
2016
Q4 		$5.96M Hold
492,631
– – ﹤0.01% 1829
2016
Q3 		$4.63M Hold
492,631
– – ﹤0.01% 1884
2016
Q2 		$5.04M Hold
492,631
– – ﹤0.01% 1872
2016
Q1 		$5.97M Buy
492,631
+60,000
+14% +$607K ﹤0.01% 1771
2015
Q4 		$6.93M Hold
432,631
– – ﹤0.01% 1769
2015
Q3 		$5.56M Buy
432,631
+1,236
+0.3% +$24.9K ﹤0.01% 1815
2015
Q2 		$10.4M Hold
431,395
– – 0.01% 1602
2015
Q1 		$8.1M Buy
431,395
+100,171
+30% +$2.07M ﹤0.01% 1737
2014
Q4 		$6.25M Buy
+331,224
New +$7.74M ﹤0.01% 1847

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank's EPZM Position: Q2 2022 in Review

Norges Bank sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 238,162 shares — an estimated $274K sold.

Norges Bank first reported a position in EPZM in Q4 2014 and held it in 30 quarters. The position peaked at $22.5M in Q3 2017. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Norges Bank reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Norges Bank sold 238,162 Epizyme, Inc shares in Q2 2022, an estimated $274K.
  • Norges Bank first reported a position in Epizyme, Inc in Q4 2014 and held it in 30 quarters.
  • Norges Bank's Epizyme, Inc position peaked at $22.5M in Q3 2017.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Norges Bank's 13F filing for Q2 2022, filed 11 Aug 2022.